bradley mcgregor, md, on impressions of the oral inhibitor study in renal cell carcinoma patients
Published 4 years ago • 47 plays • Length 1:19
Download video MP4
Download video MP3
Similar videos
-
1:01
bradley mcgregor, md, describes if biomarkers help guide treatment in advanced renal cell carcinoma
-
1:39
david quinn, md, on impressions of the oral inhibitor study in renal cell carcinoma patients
-
1:13
bradley mcgregor, md, on mrcc patients whose cancer returns and were previously treated with i-o
-
2:09
bradley mcgregor, md, considers the optimal approach to treating newly diagnosed rcc patients
-
1:34
dr mcgregor on the clinical implications of the dad-io trial in urothelial carcinoma
-
1:18
bradley mcgregor, md, considers strategies for treating 2nd line rcc patients
-
1:29
bradley mcgregor, md, on combo ipilimumab nivolumab in variant histologies of bladder cancer
-
1:49
dr. mcgregor on immunotherapy combinations in kidney cancer
-
1:16
bradley mcgregor, md, on the data regarding enfortumab in post-platinum i-o bladder cancer
-
1:47
dr. mcgregor on choosing a combination therapy regimen in advanced rcc
-
1:54
dr. mcgregor on immunotherapy in rare genitourinary cancers
-
0:53
dr. mcgregor on challenges facing frontline treatments for rcc
-
1:18
dr mcgregor on the rationale for the dad trial in metastatic urothelial cancer
-
0:59
dr. mcgregor on future research in mcrpc
-
1:44
dr. mcgregor on treating genitourinary cancer | dana-farber cancer institute
-
2:28
david braun, md on kidney cancer
-
1:42
eric jonasch, md, explains mk-6482 and the tumor types it will be most effective in
-
1:28
dr. braun on evolution of immunotherapy in advanced renal cell carcinoma
-
1:12
the slim modiolar and hearing preservation
Clip.africa.com - Privacy-policy